Alteration in Electroencephalogram and Monoamine Concentrations in Rat Brain following Ibogaine Treatment
- 1 May 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 844 (1) , 265-273
- https://doi.org/10.1111/j.1749-6632.1998.tb08241.x
Abstract
Ibogaine (IBO) is a psychoactive indole alkaloid that has antiaddictive properties. However, treatment with IBO may lead to neurotoxicity, since IBO and its metabolites interact persistently with many neurotransmitter systems. Here, we recorded cortical electroencephalogram (EEG) signals from rats anesthetized with isoflurane. The heart rate (HR) was monitored via electrocardiogram (EKG) electrodes. After the baseline EEG was recorded, rats received one intraperitoneal (i.p.) dose of 50 mg/kg IBO. EEG signals were recorded for 2 hr. Rats were then sacrificed and brains dissected into frontal cortex (FC), caudate nucleus (CN), hippocampus (HIP), and brain stem (BS). The level of dopamine (DA), serotonin (5-HT), and their metabolites were determined by high-performance liquid chromatography with electrochemical detection (HPLC-ECD). Compared with baseline, a decrease in HR immediately after IBO injection and a decrease in δ, θ, α, and β power spectra frequency bands (1-4, 4-8, 8-13, 13-32Hz) during the first 30 min after IBO administration was observed. EEG recovered within the next 15 min. In CN, the level of DA decreased and DA turnover rate increased significantly. The levels of 5-HT increased in FC. The pattern of EKG and EEG response to IBO may be due to multiple receptor interactions of IBO.Keywords
This publication has 15 references indexed in Scilit:
- Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluationBrain Research, 1996
- Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, CerebellumAnnals of the New York Academy of Sciences, 1996
- Ibogaine neurotoxicity: a re-evaluationBrain Research, 1996
- Ibogaine-like effects of noribogaine in ratsBrain Research, 1996
- Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninLife Sciences, 1995
- Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatumBrain Research, 1994
- Inhibitory effects of ibogaine on cocaine self-administration in ratsEuropean Journal of Pharmacology, 1993
- Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in ratsLife Sciences, 1992
- Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremorNeuropharmacology, 1992
- Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsBrain Research, 1992